SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $639 | -23.9% | 23,200 | -16.8% | 0.00% | -33.3% |
Q2 2023 | $840 | -99.4% | 27,900 | +298.6% | 0.01% | +500.0% |
Q3 2020 | $146,000 | -91.8% | 7,000 | -90.7% | 0.00% | -92.9% |
Q4 2019 | $1,781,000 | -8.6% | 75,100 | +5.9% | 0.01% | -12.5% |
Q3 2019 | $1,948,000 | -17.1% | 70,900 | -0.1% | 0.02% | -20.0% |
Q2 2019 | $2,349,000 | -16.9% | 71,000 | -12.0% | 0.02% | -23.1% |
Q1 2019 | $2,828,000 | +13.3% | 80,700 | +7.5% | 0.03% | +18.2% |
Q4 2018 | $2,495,000 | -35.9% | 75,100 | -2.8% | 0.02% | -26.7% |
Q3 2018 | $3,892,000 | +27.3% | 77,300 | +51.3% | 0.03% | +15.4% |
Q2 2018 | $3,058,000 | +3.5% | 51,100 | -20.8% | 0.03% | -7.1% |
Q1 2018 | $2,954,000 | -6.3% | 64,500 | -18.5% | 0.03% | +3.7% |
Q4 2017 | $3,152,000 | +32.5% | 79,100 | -17.8% | 0.03% | +3.8% |
Q3 2016 | $2,379,000 | -51.1% | 96,200 | -59.7% | 0.03% | -51.9% |
Q2 2016 | $4,862,000 | +4.8% | 238,700 | -21.5% | 0.05% | +3.8% |
Q1 2016 | $4,638,000 | -15.6% | 304,100 | -25.6% | 0.05% | -26.8% |
Q4 2015 | $5,493,000 | – | 408,700 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |